Brain Neoplasm: Clinical Trials

10 trials for Brain Neoplasm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 terminated, 1 not yet recruiting, 1 recruiting. 10 Phase 1, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 110Completed 5, Terminated 2, Not yet recruiting 1, Recruiting 1, Unknown 1
Phase 24Completed 2, Recruiting 1, Terminated 1

Follow Brain Neoplasm: new trials by email Literature Review of Brain Neoplasm trials Research Report on Brain Neoplasm

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of SRN-101 Administered Prior to Surgical Resection in Adults With Recurrent High-Grade Glioma.
SRN-101, Blood Specimen Collection, Surgical Resection - Recurrent High-Grade Gliomas, Brain Neoplasm
Phase 1Not yet recruitingNicholas Butowski62026-11-152026-10-27
Fractionated Stereotactic Radiosurgery With Concurrent Bevacizumab for Brain Metastases: A Phase I Dose-escalation Trial
Fractionated stereotactic radiosurgery, bevacizumab - Brain Neoplasm
Phase 1UnknownNational Taiwan University Hospital362018-01-012017-08-18
Cetuximab-IRDye 800CW in Detecting Tumors in Patients With Malignant Glioma Undergoing Surgery
Cetuximab, Cetuximab-IRDye 800CW, Tumor resection - Brain Neoplasm, Malignant Glioma
Phase 1 / Phase 2TerminatedEben Rosenthal32016-10-012020-03-31
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
Intra-arterial Cetuximab, Intra-arterial Mannitol - Glioblastoma, Brain Cancer
Phase 1 / Phase 2RecruitingNorthwell Health332016-06-012026-06-01
An Open Label Dose Escalation Safety Study of Convection-Enhanced Delivery of IL13-PE38QQR in Patients With Progressive Pediatric Diffuse Infiltrating Brainstem Glioma and Supratentorial High-grade Glioma
IL13-PE38QQR - Brain Neoplasm, Glioma
Phase 1TerminatedNational Institute of Neurological Disorders and Stroke (NINDS)72009-04-072018-07-05
Monteris AutoLITTâ„¢ FIM Safety Trial for Recurrent/Progressive Brain Tumors
AutoLITT system - Brain Tumor, Brain Tumor, Recurrent
Phase 1CompletedMonteris Medical102008-08-012021-08-24
Safety and Tolerability Study of 131I-TM-601 to Treat Adult Patients With Recurrent Glioma.
131I-TM-601 - Glioma, Brain Neoplasm
Phase 1 / Phase 2CompletedTransMolecular182002-06-012009-03-31
Clinical Study on 5-aminolevulinic Acid Hydrochloride (5-ALA) for Fluorescence-guided Resection of Malignant Gliomas
Gliolan - Brain Neoplasm
Phase 1 / Phase 2Completedmedac GmbH212000-02-012016-05-23
Gene Therapy for the Treatment of Brain Tumors
Cytovene (Ganciclovir Sodium), G1TKSVNa.53 Producer Cell Line - Brain Neoplasm, Neoplasm Metastasis
Phase 1CompletedNational Institute of Neurological Disorders and Stroke (NINDS)151992-08-212017-07-02
A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas
Motexafin Gadolinium Injection - Glioma, Glioblastoma
Phase 1CompletedPharmacyclics LLC.242009-04-03

Narrower conditions

Brain Neoplasms (10)  ·  Glioma (5)  ·  Glioblastoma (3)  ·  Astrocytoma (1)  ·  Multiple Acyl Coenzyme A Dehydrogenase Deficiency (1)  ·  Neoplasm Metastasis (1)  ·  Neoplasms (1)  ·  Oligodendroglioma (1)

Broader conditions

Brain Diseases (10)  ·  Central Nervous System Diseases (10)  ·  Central Nervous System Neoplasms (10)  ·  Neoplasms by Site (10)  ·  Nervous System Diseases (10)  ·  Nervous System Neoplasms (10)  ·  Neoplasms (9)  ·  Neoplasms by Histologic Type (7)  ·  Neoplasms, Germ Cell and Embryonal (7)  ·  Neoplasms, Glandular and Epithelial (7)  ·  Neoplasms, Nerve Tissue (7)  ·  Neoplasms, Neuroepithelial (7)  ·  Neuroectodermal Tumors (7)  ·  Astrocytoma (2)  ·  Glioma (2)

Interventions

Aminolevulinic Acid (1)  ·  Antibodies, Monoclonal (1)  ·  Bevacizumab (1)  ·  Blood Specimen Collection (1)  ·  Cetuximab (1)  ·  Chlorotoxin (1)  ·  Ganciclovir (1)  ·  IL13-PE38 (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Transurethral Resection of Bladder (1)  ·  motexafin gadolinium (1)

Sponsors

National Institute of Neurological Disorders and Stroke (NINDS) (2)  ·  Eben Rosenthal (1)  ·  Monteris Medical (1)  ·  National Taiwan University Hospital (1)  ·  Nicholas Butowski (1)  ·  Northwell Health (1)  ·  Pharmacyclics LLC. (1)  ·  TransMolecular (1)  ·  medac GmbH (1)

Countries

United States (8)  ·  Taiwan (1)

Top investigators

Andrew Sloan, MD (1)  ·  Chia-Chun Wang (1)  ·  Diana M Hablitz, MSNCRNP (1)  ·  Eben Rosenthal, MD (1)  ·  Gene Barnett, MD (1)  ·  Gordon Li, MD (1)  ·  John D Heiss, M.D. (1)  ·  Nicholas Butowski, MD (1)

Results publications

PMID 23560574, PMID 24410126, PMID 24792486

NIH funding

P30CA124435 (1)